Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

China In Vitro Fertilization Market is projected to surpass USD 2.8 Billion by 2025

(Medical-NewsWire.com, February 21, 2020 ) Renub Research report titled “China In Vitro Fertilization Market, (IVF) by Treatment (Fresh Embryo, Frozen Embryo, Donor Egg, Others), Instruments (Culture Media, Disposable Devices, Capital Equipment), Procedure (ICSI IVF, Non-ICSI IVF, IUI), End-User (Fertility Clinics, Hospitals, Others)” provides a complete analysis of China In Vitro Fertilization (IVF) Market.





Every year, worldwide, thousands of cycles of in vitro fertilization (IVF) are carried out. Major factors driving the IVF sector globally are growth in the median age of motherhood, lower fertility rates, increasing male infertility due to increased use of alcohol and cigarettes, and growing public awareness of infertility and the available treatment options. For women, chances of conceiving decrease after age 32 and by age 40, rates of fertility decline by half. Likewise, for males, the amount of semen and sperm motility (the sperm's ability to move towards an egg) declines gradually between the ages of 20 and 80. In addition, women who postpone pregnancy are at a higher risk of pregnancy-related health problems, including low birth weight, miscarriage, fetal abnormalities, premature delivery, prolonged labor and maternal morbidity. China In Vitro Fertilization Market is projected to surpass USD 2.8 Billion by 2025.





Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=china-in-vitro-fertilization-market-p.php





However, a major factor limiting the adoption of IVF treatment is the high cost of IVF procedures. Multiple births occur after 39 percent of IVF treatments, according to the Institute for Health Policy Studies at the University of California in the US, whereas in Europe they are 26 percent. However, the risk of birth after the procedure is relatively low. The IVF treatment success rate is only 28 percent to 35 percent, which declines with the woman's age. The success rate, for instance, was 32.2% for women under 35, 27.7% for women aged 35 to 37, 20.8% for women aged 38 to 39, 13.6% for women aged 40 to 42, 5% for women aged 43 to 44, and 1.9% for women aged over 44.





Market Summary:



By Treatment: The China In-Vitro fertilization (IVF) is divided into four segments; Fresh Embryo, Frozen Embryo, Donor Egg and Others



By End User: The global IVF market was segmented into fertility clinics and surgical centers, hospitals and others based on end-users. It is projected that the category of fertility clinics and surgical centers will dominate the largest share of the global market in 2018. It is also projected that this segment will record the highest CAGR over the forecast period.



By Instruments: This report provides full market insight by instruments; Culture Media, Disposable Devices and Capital Equipment





Renub Research Infographic Zone: https://renubresearchinfographiczone.blogspot.com/





Key Topics Covered :



1. Introduction



2. Research Methodology



3. Executive Summary



4. China In-Vitro Fertilization Market



5. China In-Vitro Fertilization Numbers



6. Market Share – China In-Vitro Fertilization



6.1 By Treatment

6.2 By Instrument

6.3 By Procedure

6.4 By End User





7. Treatment – China In-Vitro Fertilization Market



7.1 Fresh Embryo

7.2 Frozen Embryo

7.3 Donor Egg

7.4 Others





8. Instrument – China In-Vitro Fertilization Market



8.1 Culture Media

8.2 Disposable Devices

8.3 Capital Equipment





9. Procedure – China In-Vitro Fertilization Market



9.1 ICSI IVF

9.2 Non-ICSI IVF

9.3 IUI





10. End User – China In-Vitro Fertilization Market



10.1 Fertility Clinics

10.2 Hospitals

10.3 Others





11. Growth Drivers



11.1 Delayed Pregnancies in Women

11.2 Rise in Infertility Rates

11.3 Surge in IVF Success Rates

11.4 Growth in Disposable Income of Consumers





12. Challenges



12.1 Embryo Smuggling Cases Affecting IVF Services Market

12.2 Unaffordable Cost of Assisted Reproductive Techniques (ART)





If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.





Browse Related Report :



China Cancer Drugs Market @ https://www.renub.com/china-cancer-drugs-market-p.php



China Vaccine Market @ https://www.renub.com/china-vaccine-market-p.php





About Us:



Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.





Contact Us

Renub Research

Phone: +1-678-302-0700

Email: info@renub.com

Website: www.renub.com

Follow us on LinkedIn: www.linkedin.com/company/renub-research

Renub Research

Rajat Gupta

Market Research, Bus

rajat.gupta@renub.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC